Fabrizio Tagliavini has a degree in Medicine and Surgery and a specialization in Neurology and Neuropathology. For over 30 years his clinical and research activities have been focused on degenerative dementias due to protein misfolding – in particular Alzheimer disease, prion encephalopathies and frontotemporal dementias. His scientific activity has resulted in the publication of more than 300 articles in prestigious international journals, including Nature, Nature Medicine, Nature Reviews Neurology, Science, Cell, Neuron, EMBO Journal, Proceedings of the National Academy of Sciences USA, Lancet and Lancet Neurology.See CV complete.
A new therapeutic approach to AD
A genetic mutation was identified in a case of Azheimer’s disease that made it possible to experiment new therapies.
